Validation of the Ankylosing Spondylitis Disease Activity Score with a Quick Quantitative Creactiveprotein Assay (ASDAS-qCRP) in Patients with Axial Spondyloarthritis (axSpA): Aprospective, National, Multicenter Study - ACR Meeting Abstracts

Por um escritor misterioso

Descrição

Background/Purpose: According to international recommendations, the Ankylosing Spondylitis Disease Activity Score (ASDAS) is the preferred score for assessing disease activity in axial spondyloarthritis (axSpA) [1]. However, routine determination of C-reactive protein (CRP) to calculate ASDAS values takes hours to days. This limits the use of ASDAS in clinical routine and clinical trials and hinders the […]
Validation of the Ankylosing Spondylitis Disease Activity Score with a  Quick Quantitative Creactiveprotein Assay (ASDAS-qCRP) in Patients with  Axial Spondyloarthritis (axSpA): Aprospective, National, Multicenter Study  - ACR Meeting Abstracts
Higher disease activity leads to more structural damage in the
Validation of the Ankylosing Spondylitis Disease Activity Score with a  Quick Quantitative Creactiveprotein Assay (ASDAS-qCRP) in Patients with  Axial Spondyloarthritis (axSpA): Aprospective, National, Multicenter Study  - ACR Meeting Abstracts
OP0107 ETANERCEPT WITHDRAWAL AND RE-TREATMENT IN PATIENTS WITH
Validation of the Ankylosing Spondylitis Disease Activity Score with a  Quick Quantitative Creactiveprotein Assay (ASDAS-qCRP) in Patients with  Axial Spondyloarthritis (axSpA): Aprospective, National, Multicenter Study  - ACR Meeting Abstracts
Simplified Ankylosing Spondylitis Disease Activity Score (SASDAS
Validation of the Ankylosing Spondylitis Disease Activity Score with a  Quick Quantitative Creactiveprotein Assay (ASDAS-qCRP) in Patients with  Axial Spondyloarthritis (axSpA): Aprospective, National, Multicenter Study  - ACR Meeting Abstracts
Reviewing Disease Activity Indices in Spondyloarthritis From the
Validation of the Ankylosing Spondylitis Disease Activity Score with a  Quick Quantitative Creactiveprotein Assay (ASDAS-qCRP) in Patients with  Axial Spondyloarthritis (axSpA): Aprospective, National, Multicenter Study  - ACR Meeting Abstracts
PDF) ASAS40 and ASDAS clinical responses in the ABILITY-1 clinical
Validation of the Ankylosing Spondylitis Disease Activity Score with a  Quick Quantitative Creactiveprotein Assay (ASDAS-qCRP) in Patients with  Axial Spondyloarthritis (axSpA): Aprospective, National, Multicenter Study  - ACR Meeting Abstracts
PDF) Performance of the Ankylosing Spondylitis Disease Activity
Validation of the Ankylosing Spondylitis Disease Activity Score with a  Quick Quantitative Creactiveprotein Assay (ASDAS-qCRP) in Patients with  Axial Spondyloarthritis (axSpA): Aprospective, National, Multicenter Study  - ACR Meeting Abstracts
FRI0126 The Ankylosing Spondylitis Disease Activity Score (ASDAS
Validation of the Ankylosing Spondylitis Disease Activity Score with a  Quick Quantitative Creactiveprotein Assay (ASDAS-qCRP) in Patients with  Axial Spondyloarthritis (axSpA): Aprospective, National, Multicenter Study  - ACR Meeting Abstracts
Etanercept Withdrawal and Retreatment in Nonradiographic Axial
Validation of the Ankylosing Spondylitis Disease Activity Score with a  Quick Quantitative Creactiveprotein Assay (ASDAS-qCRP) in Patients with  Axial Spondyloarthritis (axSpA): Aprospective, National, Multicenter Study  - ACR Meeting Abstracts
High disease activity according to the Ankylosing Spondylitis
Validation of the Ankylosing Spondylitis Disease Activity Score with a  Quick Quantitative Creactiveprotein Assay (ASDAS-qCRP) in Patients with  Axial Spondyloarthritis (axSpA): Aprospective, National, Multicenter Study  - ACR Meeting Abstracts
Simplified Ankylosing Spondylitis Disease Activity Score (SASDAS
Validation of the Ankylosing Spondylitis Disease Activity Score with a  Quick Quantitative Creactiveprotein Assay (ASDAS-qCRP) in Patients with  Axial Spondyloarthritis (axSpA): Aprospective, National, Multicenter Study  - ACR Meeting Abstracts
PDF) POS0241 VALIDATION OF THE ANKYLOSING SPONDYLITIS DISEASE
de por adulto (o preço varia de acordo com o tamanho do grupo)